Surgical Tables - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Surgical Tables - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

The surgical tables market is projected to register a CAGR of 3.2% during the forecast period.

Key Highlights

• The pandemic had a significant impact on the market studied. There were strict guidelines specific to each specialty that had to be implemented and followed for surgeons to be able to continue to provide safe and effective care to their patients during the COVID-19 pandemic. The volume of surgeries declined significantly during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries. However, the initiatives by key players, such as increasing product launches, contributed to the market growth. For instance, in May 2022, Dornier launched its new flagship urology table, the Nautilus, after receiving Food Drug Administration (FDA) clearance and CE mark approval.
• The Nautilus enables high-resolution imaging from unprecedented angles with a flexible full-ranged C-arm and precise multi-axis table movements, featuring independent movement or sophisticated synchronization. The unique C-arm movement and parking position allow the Nautilus to be used as a free-standing urology treatment table with true 360° table access for endoscopic and surgical procedures. In addition, its X-ray tube can be flexibly positioned below the patient table, enabling enhanced radiation management.
• The major factor attributing to the growth of the market is the rising number of surgeries across the globe. This is due to the increasing number of trauma and injury cases across the globe. Moreover, the rising burden of chronic disease across the globe is also one of the major factors increasing the demand for surgical tables, as end-stage chronic diseases generally demand surgery. For instance, According to the American Cancer Society 2023 Cancer Statistics, the estimated new number of cancer cases is estimated to be 1.9 million in the United States in 2023. This estimation includes 1.1 million number of males and 948,000 cases of females. The high burden of cancer is augmenting the demand for medical devices and thereby boosting the market growth over the forecast period.
• Furthermore, as per the data from the CARES Report 2021, 97.6% of adults and 2.4% of children were reported with out-of-hospital cardiac (OHCA) arrest in 2021 in the United States, and the median age of OHCA is considered to be 64 years. Hence, to cope with the rising prevalence of cardiac complications globally, early diagnosis of risk factors associated with cardiac arrest is being broadly carried out across the globe, which is fueling the market growth.
• Additionally, the increased prevalence of different types of neurological diseases is likely to increase the demand for medical devices. For instance, as per the 2022 update from the National Brain Tumor Society, an estimated 700,000 people in the United States were living with a primary brain tumor, and approximately 88,970 more were likely to be diagnosed in 2022. Glioblastoma is the most commonly occurring primary malignant brain tumor, accounting for 14.3% of all tumors and 49.1% of all malignant tumors in 2022.
• Hence, the high prevalence of neurological disease contributes to increasing the demand for neurology-related medical devices and is anticipated to increase in the future. Thus, this growth in the number of surgical procedures is likely to increase the demand for surgical tables, thereby contributing to market growth.
• Chronic diseases, such as cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, ocular disorders, etc., are often accompanied by various surgical procedures over the life span of the individual. Additionally, according to a research study published in the Journal of Thoracic Disease in April 2021, there has been significant progress in the development and adoption of minimally invasive techniques in cardiac surgery. In cardiac surgery, the median sternotomy has been, and remains, the trusted, well-established, and gold-standard access route for many decades.
• Adding to that, to support minimally invasive surgeries, a professional society emerged: the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). The growing number of procedures implies more attention toward the facilities available inside the operation theatre rooms. Thus, the importance and demand for surgical tables continue to grow steadily.
• Furthermore, rising investments in surgical instruments by hospitals are boosting the market. However, the lack of skilled labor is the major drawback of market growth.

Surgical Tables Market Trends

General Surgical Table is Expected to Witness Strong Growth Over the Forecast Period

• General surgeries, including cardiovascular, gastroenterology, ENT, orthopedic, and gynecology, are some of the most common general surgeries. Owing to the high penetration of general surgeries in the market, the demand for general surgical tables is also high. General surgical tables are the ones on which a patient lies down during a surgical procedure. Their demand is higher than the specialty tables, as the special ones are used only in very few cases in very few hospitals. Therefore, as the number of surgeries increases, the market growth also expands.
• Research studies are another factor in market growth. For instance, as per the data from the CARES Report 2021, 97.6% of adults and 2.4% of children were reported with out-of-hospital cardiac arrest in 2021 in the United States, and the median age of Oklahoma Health Care Authority (OHCA) is considered to be 64 years. Hence, to cope with the rising prevalence of cardiac complications globally, early diagnosis of risk factors associated with cardiac arrest is being broadly carried out across the globe, which is fueling the market growth. Thus, the rising demand for surgeries around the world will drive the growth of the segment during the forecast period.
• Technological advancements and novel products in these surgical tables are some of the major factors propelling the market growth. For instance, in October 2021, Stille AB entered an exclusive collaboration with GE Healthcare for a new general surgery table in the United States. The new general surgery table, GS2, has been developed to address a growing need for a premium general surgery table that satisfies the needs of multi-disciplinary surgery units such as ambulatory surgery centers (ASC) while providing a cost-effective, high-value solution.
• Hence, due to the above-mentioned factors, the market is likely to grow in the future.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the surgical tables market over the forecast period. The positive reimbursement situation in the United States, the increasing inclination toward minimally invasive surgeries, and the soaring number of surgeries are the major factors driving the growth of the surgical tables market in North America. Furthermore, growing awareness among the population to approach surgical procedures in case of injuries and chronic disease problems is also driving the market growth.

The rising number of surgeries concerning cardiovascular and neurological diseases within the North American region is likely to have a positive impact on market growth. For instance, according to the CDC 2022 update, a total of 18.2 million adults had coronary artery disease, and approximately 70% of these patients underwent surgery. Moreover, there are nearly 35 million hospital stays each year in the United States. Hence, this rise in hospital stays and surgeries is likely to have a positive impact on the market's growth. With the rising burden of chronic diseases, the Canadian government is investing heavily to improve the healthcare infrastructure. For instance, as per the press release published in July 2021 by the government of Canada, the governments of Canada and Quebec collaborated to invest in 209 infrastructure projects to modernize, redevelop, and upgrade the health and social services institutions in Quebec, including hospitals, and other care centers. Federal Minister of Infrastructure and Communities, and Minister of Health and Social Services, announced a total of USD 188.3 million in funding for these 209 infrastructure projects. These investments demand the availability of surgical tables in hospitals.

Moreover, there is a huge presence of key players in the market in this region, owing to which the region is expected to propel at high growth rates. Collaborations between key market players are another factor in market growth. For instance, in December 2022, HSHS St. Anthony's Memorial Hospital has become the first hospital in the United States and even in North and South America to install and begin using the newly developed Nautilus operating table and x-ray system from Dornier MedTech. Additionally, high-resolution imaging from unprecedented positions and angles offers doctors a wider area to x-ray in one image, helping with better diagnosis and treatment. These healthcare facilities perform procedures across a wide spectrum of surgical disciplines alongside the OEC C-arms such as orthopedics, general surgery, cardiovascular, and urology, as well as non-fluoroscopic specialties like plastic surgery, and thus require a highly versatile surgical table. Hence, such developments would increase market growth in the upcoming future.

Hence, due to the above-mentioned factors, the market is expected to grow in the future.

Surgical Tables Industry Overview

The surgical tables market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Steris PLC, Skytron LLC, Stryker Corporation, Mizuho OSI, Getinge AB, Schaerer Medical USA Inc., NUVO Inc., Allengers Medical Systems Limited, Invacare Corp., Elekta AB, and Trumpf Medical.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support